Halcyon Drugs And Formulation Private Limited, a active private limited company, was established on 30 November 2005 in Kanpur, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232UP2005PTC031018. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.80 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sujeet Sahu (Director), Rajesh Sahu (Director), Brijesh Kumar Sahu (Director). Past directors included Payal Sahu, Alka Shah, Uma Shankar Shah. It holds no open charges and ₹1.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 102, Raman Villa Apartment 160-E Block, Shyam Nagar, Kanpur, Uttar Pradesh, 208013.
U24232UP2005PTC031018
031018
30 November 2005
₹0.80 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Halcyon Drugs And Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujeet Sahu | Director | 30 Nov 2005 | Current |
| Rajesh Sahu | Director | 01 Apr 2025 | Current |
| Brijesh Kumar Sahu | Director | 01 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 13 Dec 2012 | Past |
| Pramod Abcsdd | Director | 13 Dec 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Halcyon Drugs And Formulation Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 12.47% decrease. The company also saw a substantial fall in profitability, with a 60.3% decrease in profit. The company's net worth dipped by a decrease of 1.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Halcyon Drugs And Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2009 | Bank Of India | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Halcyon Drugs And Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Halcyon Drugs And Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Halcyon Drugs And Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rajesh Sahu was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 8 months 2 days . was completed.
The activity Brijesh Kumar Sahu was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 8 months 2 days . was completed.
Progress on Halcyon Drugs And Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Halcyon Drugs And Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
Progress on A charge registered on 24 Jan 2009 via Charge ID 10142349 with Bank Of India was fully satisfied on 23 May 2019. was documented.
A charge with Bank Of India of Rs. 1.50 M registered on 24 Jan 2009 with Charge ID 10142349 was modified on 19 Aug 2010. was recorded as a recent event.
The CIN of Halcyon Drugs And Formulation Private Limited is U24232UP2005PTC031018.
Halcyon Drugs And Formulation Private Limited is headquartered at Flat No. 102, Raman Villa Apartment 160-E Block, Shyam Nagar, Kanpur, Uttar Pradesh, 208013.
Halcyon Drugs And Formulation Private Limited was incorporated on 30 November 2005.
The current directors of Halcyon Drugs And Formulation Private Limited are
The primary industry of Halcyon Drugs And Formulation Private Limited is Pharma.
Halcyon Drugs And Formulation Private Limited is unlisted.
The authorized capital of Halcyon Drugs And Formulation Private Limited is ₹0.80 M, and the paid-up capital is ₹0.10 M.
The compliance status of Halcyon Drugs And Formulation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX